z-logo
Premium
Pertussis toxin‐sensitive activation of phospholipase A 2 can be resolved from phosphoinositidase C in primary cultures of mouse osteoblasts using indomethacin
Author(s) -
Sandy Jonathan R.,
Meikle Murray C.,
Farndale Richard W.
Publication year - 1993
Publication title -
journal of bone and mineral research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.882
H-Index - 241
eISSN - 1523-4681
pISSN - 0884-0431
DOI - 10.1002/jbmr.5650080505
Subject(s) - pertussis toxin , arachidonic acid , eicosanoid , phospholipase c , medicine , endocrinology , eicosanoid metabolism , biology , phospholipase a2 , phospholipase , g protein , osteoblast , biochemistry , chemistry , enzyme , receptor , in vitro
Recent work has established that various bone‐resorbing hormones are able to activate phosphoinositide metabolism as well as eicosanoid production in osteoblast‐like cells, although the relationship between these pathways is unclear. We used pertussis toxin and indomethacin to inhibit the stimulation of [ 3 H]arachidonic acid release and [ 3 H]phosphoinositide turnover caused by treating primary cultures of mouse osteoblasts with fetal calf serum. We found (1) that pertussis toxin and indomethacin each inhibited both pathways and (2) that although pertussis toxin inhibited [ 3 H]arachidonic acid release to a greater extent than indomethacin, [ 3 H]inositol phosphate accumulation was inhibited rather more effectively by indomethacin. These data suggest that whereas ligands in fetal calf serum activate [ 3 H]arachidonic acid release largely directly via the action of a pertussis‐sensitive G protein, activation of phosphoinositidase C is indirect, being substantially dependent upon eicosanoid production. These experiments suggest that serial activation of phospholipase A 2 and phosphoinositidase C may occur in osteoblasts and that only the former enzyme is regulated by a pertussis toxin‐sensitive G protein.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here